November 18, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the first at-home COVID-19 self-test kit. The product was developed by Lucira and offers results within 30 minutes.
Lucira's COVID-19 All-In-One test kit is a molecular real-time loop-mediated amplification reaction single-use test that aims to detect infection with the SARS-CoV-2 virus. Other COVID-19 diagnostic tests have been authorized for at-home collection, but Lucira's is the first that can be fully self-administered and provides results at home.
The test is authorized for home use with self-collected nasal swab samples in individuals who are at least 14 years old and are suspected of having COVID-19 by their healthcare providers. Also, it is authorized for use in point-of-care settings for all ages.
In point-of-care settings, samples must be collected by a healthcare provider when it is being used to test individuals younger than 14. Currently, All-In-One is authorized for prescription use only.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current